Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Tipo de estudio
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Oncogene ; 36(18): 2619-2627, 2017 05 04.
Artículo en Inglés | MEDLINE | ID: mdl-27941888

RESUMEN

CIB1 (calcium and integrin binding protein 1) is a small intracellular protein with numerous interacting partners, and hence has been implicated in various cellular functions. Recent studies have revealed emerging roles of CIB1 in regulating cancer cell survival and angiogenesis, although the mechanisms involved have remained largely undefined. In investigating the oncogenic function of CIB1, we initially found that CIB1 is widely up-regulated across a diverse range of cancers, with this upregulation frequently correlating with oncogenic mutations of KRas. Consistent with this, we found that ectopic expression of oncogenic KRas and HRas in cells resulted in elevated CIB1 expression. We previously described the Ca2+-myristoyl switch function of CIB1, and its ability to facilitate agonist-induced plasma membrane localisation of sphingosine kinase 1 (SK1), a location where SK1 is known to elicit oncogenic signalling. Thus, we examined the role this may play in oncogenesis. Consistent with these findings, we demonstrated here that over-expression of CIB1 by itself is sufficient to drive localisation of SK1 to the plasma membrane and enhance the membrane-associated enzymatic activity of SK1, as well as its oncogenic signalling. We subsequently demonstrated that elevated levels of CIB1 resulted in full neoplastic transformation, in a manner dependent on SK1. In agreement with our previous findings that SK1 is a downstream mediator of oncogenic signalling by Ras, we found that targeting CIB1 also inhibited neoplastic growth of cells induced by oncogenic Ras, suggesting an important pro-tumorigenic role for CIB1. Thus, we have demonstrated for the first time a role for CIB1 in neoplastic transformation, and revealed a novel mechanism facilitating oncogenic signalling by Ras and SK1.


Asunto(s)
Proteínas de Unión al Calcio/genética , Neoplasias/genética , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética , Proteínas Proto-Oncogénicas p21(ras)/genética , Calcio/metabolismo , Carcinogénesis/genética , Línea Celular Tumoral , Membrana Celular/genética , Supervivencia Celular , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Neoplasias/patología , Proteínas Proto-Oncogénicas p21(ras)/biosíntesis
2.
Braz J Biol ; 76(2): 444-9, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27007505

RESUMEN

We report six new occurrence records of the bush dog Speothos venaticus, a widely distributed South American carnivore that is threatened with extinction. These records are accompanied by notes on the places where the records were made, such as vegetation type, date and information about the protection of areas. The records, obtained over the last 17 years in Paraná state, southern Brazil, offer an improved understanding of the species geographic range and the threats it faces and can enable better assessments of the conservation status of the species in southern Brazil.


Asunto(s)
Canidae , Especies en Peligro de Extinción , Animales , Brasil/epidemiología , Dinámica Poblacional/estadística & datos numéricos
3.
Br J Pharmacol ; 119(4): 685-90, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8904642

RESUMEN

1. We have used rings of rabbit thoracic aorta to investigate the vasorelaxant properties of two different classes of non-ionic iodinated radiographic contrast media (IRCM) and the mechanisms, underlying their mode of action. Iohexol (a triiodinated monomer) was compared with iodixanol (a hexaiodinated dimer). 2. Iohexol and iodixanol both relaxed phenylephrine (0.3 microM) constricted rabbit aorta in a concentration-dependent manner that did not depend on the presence of an intact endothelium. When expressed as a function of iodine concentration, iodixanol caused significantly less relaxation than iohexol. However, the extent of relaxation was similar for both IRCM when expressed on a molar basis. Furthermore, increasing the molarity of the buffer to comparable levels with mannitol evoked only a small (approximately 15%) relaxation of phenylephrine-induced tone. 3. Ouabain (10 microM) significantly inhibited both iohexol- and iodixanol-induced relaxations by approximately 30%. 5-(N-Ethyl-N-isopropyl)-amiloride (EIPA, 100 nM) significantly inhibited iohexol-induced relaxation to the same extent as ouabain, but did not alter the vasorelaxant effect of iodixanol. Co-incubation with ouabain and EIPA had an additive effect in the case of iohexol, increasing inhibition of relaxation to approximately 60%, whereas inhibition of iodixanol-induced relaxation by the combination of ouabain plus EIPA did not differ from that of ouabain alone. 4. Replacing NaCl with N-methyl-D-glucamine (NMDG) to lower extracellular [Na+] and thereby inhibit Na(+)-Ca2+ exchange, attenuated the relaxation evoked by iohexol or by iodixanol (by approximately 25%) in each case. 5. We conclude that iohexol- and iodixanol-induced vasorelaxation in rabbit aorta is mediated through a direct action on vascular smooth muscle that is not simply a consequence of altered osmolality. It involves modulation of the Na(+)-K+ ATPase and, in the case of iohexol, Na(+)-H+ exchange. Both agents also appear to modulate Na(+)-Ca2+ exchange, through direct and/or indirect mechanisms. This is the first study to show specific pharmacological differences between monomeric and dimeric contrast media in vascular smooth muscle.


Asunto(s)
Aorta/efectos de los fármacos , Yohexol/farmacología , Ácidos Triyodobenzoicos/farmacología , Vasodilatadores/farmacología , Animales , Aorta/fisiología , Medios de Contraste , Técnicas In Vitro , Masculino , Manitol/farmacología , Contracción Muscular/efectos de los fármacos , Concentración Osmolar , Ouabaína/farmacología , Fenilefrina/farmacología , Conejos , Sodio/metabolismo
4.
Br J Pharmacol ; 128(2): 451-7, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10510457

RESUMEN

1 We have used isolated arterial preparations from the rabbit and dog to investigate whether non-ionic iodinated radiographic contrast media (IRCM) modulate nitric oxide (NO) release. The tri-iodinated monomers iopromide and iohexol were compared with the hexa-iodinated dimer iodixanol. 2 The vasodilator effects of iohexol (300 mg ml-1) and iodixanol (320 mg ml-1) were assessed in cascade bioassay. Increasing concentrations of iohexol or iodixanol caused concentration-dependent relaxations of the detector tissue which were insensitive to 100 microM NG-nitro L-arginine methyl ester (L-NAME) and 10 microM indomethacin, whereas viscosity-associated relaxations induced by the 'inert' agent dextran (MW 80,000; 1-4%) were attenuated by inhibition of NO synthesis. 3 Relaxations of endothelium-intact rings to acetylcholine (ACh) were attenuated by preincubation with iohexol or iodixanol, whereas relaxations to sodium nitroprusside (SNP) in endothelium-denuded rings were unaffected. Inhibitory activity did not correlate with either molarity or iodine concentration. Mannitol caused inhibition of both ACh- and SNP-induced responses. 4 In isolated perfused arteries the depressor responses to iodixanol (320 mg ml-1) and iopromide (300 mg ml-1) administered as close arterial bolus attained a plateau with maximal dilatations of approximately 25% and approximately 60%, respectively. Addition of 100 microM NG-nitro L-arginine (L-NOARG) and/or 10 microM indomethacin to the perfusate had no effect on the responses to either agent. 5 We conclude that IRCM exert direct effects on the endothelium that inhibit NO production rather than its action on vascular smooth muscle. Shear stress-induced stimulation of NO production by IRCM is unlikely to contribute to their vasodilator activity in vivo when administered during angiography despite high intrinsic viscosity.


Asunto(s)
Medios de Contraste/farmacología , Endotelio Vascular/metabolismo , Yohexol/análogos & derivados , Óxido Nítrico/agonistas , Óxido Nítrico/metabolismo , Ácidos Triyodobenzoicos/farmacología , Acetilcolina/farmacología , Animales , Aorta Torácica/efectos de los fármacos , Medios de Contraste/química , Diuréticos Osmóticos/farmacología , Perros , Oído Externo/irrigación sanguínea , Endotelio Vascular/efectos de los fármacos , Técnicas In Vitro , Yohexol/química , Yohexol/farmacología , Masculino , Manitol/farmacología , Nitroprusiato/farmacología , Conejos , Flujo Sanguíneo Regional/efectos de los fármacos , Relación Estructura-Actividad , Ácidos Triyodobenzoicos/química , Vasodilatadores/farmacología , Viscosidad
5.
Curr Mol Med ; 12(10): 1207-19, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22834825

RESUMEN

FTY720 is a recently approved first line therapy for relapsing forms of multiple sclerosis. In this context, FTY720 is a pro-drug, with its anti-multiple sclerosis, immunosuppressive effects largely elicited following its phosphorylation by sphingosine kinase 2 and subsequent modulation of G protein-coupled sphingosine 1-phosphate (S1P) receptor 1 that induces lymphopenia by altering lymphocyte trafficking. A number of other biological effects of FTY720 have, however, been described, including considerable evidence that this drug also has anti-cancer properties. These other effects of FTY720 are independent of S1P receptors, and appear facilitated by modulation of a range of other recently described protein targets by nonphosphorylated FTY720. Here, we review the direct targets of FTY720 that contribute to its anti-cancer properties. We also discuss other recently described protein effectors that, in combination with S1P receptors, appear to contribute to its immunosuppressive effects.


Asunto(s)
Esclerosis Múltiple/tratamiento farmacológico , Neoplasias/tratamiento farmacológico , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Glicoles de Propileno , Esfingosina/análogos & derivados , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Clorhidrato de Fingolimod , Humanos , Inmunosupresores/farmacología , Linfopenia/inducido químicamente , Lisofosfolípidos/metabolismo , Fosforilación , Glicoles de Propileno/efectos adversos , Glicoles de Propileno/metabolismo , Glicoles de Propileno/farmacología , Receptores de Lisoesfingolípidos/metabolismo , Esfingosina/efectos adversos , Esfingosina/metabolismo , Esfingosina/farmacología
6.
Braz. j. biol ; 76(2): 444-449, Apr.-June 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-781394

RESUMEN

Abstract We report six new occurrence records of the bush dog Speothos venaticus, a widely distributed South American carnivore that is threatened with extinction. These records are accompanied by notes on the places where the records were made, such as vegetation type, date and information about the protection of areas. The records, obtained over the last 17 years in Paraná state, southern Brazil, offer an improved understanding of the species geographic range and the threats it faces and can enable better assessments of the conservation status of the species in southern Brazil.


Resumo Apresentamos seis novos registros de ocorrência do cachorro-do-mato-vinagre Speothos venaticus, um carnívoro sul Americano de ampla distribuição geográfica, porém ameaçado de extinção. Os registros são acompanhados de notas sobre os locais onde foram obtidos, tais como: tipo de vegetação, datas e informações sobre a proteção das áreas. Os registros, obtidos ao longo dos últimos 17 anos no Estado do Paraná, na região sul do Brasil, oferecem uma maior compreensão acerca da distribuição geográfica e das ameaças que a espécie enfrenta, permitindo melhores avaliações sobre o status de conservação desta espécie no sul do Brasil.


Asunto(s)
Animales , Especies en Peligro de Extinción , Canidae , Brasil/epidemiología , Dinámica Poblacional/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA